Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Yahoo Finance · 7 hours ago
Open | 140.41 |
High | 142.86 |
Low | 140.35 |
Mkt Cap | 640.66B |
P/E (TTM) | 49.78 |
Div & Yield | 1.37 & 0.99% |
Prev. Close | 138.87 |
52 Wk. Low | 75.56 |
52 Wk. High | 148.15 |
Related stocks
Danish pharmaceutical company
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 65.35B | 22.50% ▲ |
Net Income | 25.41B | 28.20% ▲ |
Diluted EPS | 0.82 | 29.40% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.77 | - |
Q1 2024 | $0.74 | $0.82 |
Q4 2023 | $0.64 | $0.70 |
S&P 500^GSPC | 5,567.19+30.17 (+0.54%) |
Dow 30^DJI | 39,375.87+67.87 (+0.17%) |
Nasdaq^IXIC | 18,352.76+164.46 (+0.90%) |
539.91+5.87% | |
171.90+4.88% | |
27.23+5.34% |